---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-23-007445"
form_type: "8-K"
ticker: null
cik: "0001404935"
company_name: "THC Therapeutics, Inc."
filed_at: "2023-10-06T23:59:59+00:00"
generated_at: "2026-06-10T03:19:36.738037+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# THC Therapeutics CEO resigns; Scott Cox appointed interim CEO; change of control via preferred stock

## Summary
- Brandon Romanek resigned as CEO on Sept 29, 2023; Scott Cox appointed Interim CEO and board member.
- Cox received 600,000 Series A Preferred shares at $0.30 each, each with 100 votes and convertible to 100 common shares.
- Preferred stock issuance constitutes a change of control of THC Therapeutics.
- Cox has over 20 years experience; currently CEO of Verde Bio Holdings (OTC: VBHI).
- Shares were issued under Section 4(a)(2) and Rule 506(b) exemption.

## SEC filing metadata
- accession: 0001477932-23-007445
- form_type: 8-K
- cik: 0001404935
- company_name: THC Therapeutics, Inc.
- filed_at: 2023-10-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.02, 5.02, 5.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1404935/000147793223007445/0001477932-23-007445-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1404935/000147793223007445/thct_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-23-007445
- JSON: https://secwatch.observer/filing/0001477932-23-007445.json
- Plain text: https://secwatch.observer/filing/0001477932-23-007445.txt

## Key facts
- Executive change
  Scott Cox was appointed as Interim Chief Executive Officer at THC Therapeutics, Inc..
  - Action: appointed
  - Role: Interim Chief Executive Officer
  source text: Scott Cox was appointed as Interim CEO of the Company
  evidence_url: https://www.sec.gov/Archives/edgar/data/1404935/000147793223007445/0001477932-23-007445-index.htm
- Executive change
  Scott Cox was appointed as Member of the Board of Directors at THC Therapeutics, Inc..
  - Action: appointed
  - Role: Member of the Board of Directors
  source text: as a member of its Board of Directors
  evidence_url: https://www.sec.gov/Archives/edgar/data/1404935/000147793223007445/0001477932-23-007445-index.htm
- Executive change
  Brandon Romanek resigned as Chief Executive Officer at THC Therapeutics, Inc..
  - Action: resigned
  - Role: Chief Executive Officer
  source text: On September 29, 2023, Brandon Romanek resigned as CEO of THC Therapeutics, Inc.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1404935/000147793223007445/0001477932-23-007445-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.